False diagnoses are used to mask inappropriate use of antipsychotic drugs on patients with dementia, a practice called chemical restraint, a government watchdog report said.

Researchers at the University of Illinois Urbana-Champaign have traced a genetic mutation found in psychosis patients to a specific breakdown in the brain’s learning machinery, offering one of the ...

Health Secretary Robert F. Kennedy Jr. is promoting food as medicine, but experts say he's overstating what diet can do for serious illness.

Imagine your dream is to get a job at the local library. You have a love for people and for books. You also have schizophrenia, a psychiatric disability that makes life in the community more ...

A JAMA Psychiatry analysis estimates schizophrenia costs the U.S. $366.8B in 2024, with nearly 80% of costs driven by indirect, cross-system impacts. Schizophrenia’s economic burden spans healthcare, ...

The marketing application for TEV-‘749 is based on results from the Phase 3 SOLARIS trial, which demonstrated an efficacy and safety profile consistent with currently available olanzapine formulations ...

Clinical trial data support the NDA for TEV-'749, demonstrating that once-monthly olanzapine improves symptoms in patients with schizophrenia. The Food and Drug Administration (FDA) has accepted for ...

What Is Bysanti, and Why Does It Matter? Bysanti (milsaperidone) is a new FDA-approved oral medicine for treating certain mental health conditions in adults. It belongs to a group of medicines called ...